South Africa (n = 342) | Zambia (n = 195) | Total (n = 537) | p-value | |
---|---|---|---|---|
Age at COVID survey (mean, SD)a | 27.8 (3.9) | 29.6 (4.7) | 28.4 (4.2) | < 0.001 |
19–24 | 88 (25.7) | 48 (24.6) | 136 (25.3) | < 0.001 |
25–30 | 195 (57.0) | 73 (37.4) | 268 (49.9) | |
31–39 | 59 (17.3) | 74 (38.0) | 133 (24.8) | |
Level of educationb | < 0.001 | |||
No schooling | 0 (0.0) | 13 (6.7) | 13 (2.4) | |
Primary school | 0 (0.0) | 73 (37.4) | 73 (13.6) | |
Secondary school, not complete | 108 (31.6) | 77 (39.5) | 185 (34.5) | |
Secondary school, complete | 148 (43.3) | 25 (12.8) | 173 (32.2) | |
Attended post-secondary school | 86 (25.2) | 7 (3.6) | 93 (17.3) | |
Parity (mean, SD)b | 1.2 (0.9) | 2.6 (1.3) | 1.7 (1.3) | < 0.001 |
Employment statusc* | < 0.001 | |||
Homemaker/Unemployed/Other | 183 (53.8) | 134 (69.4) | 317 (59.5) | |
Student | 61 (17.9) | 4 (2.1) | 65 (12.2) | |
Part or full-time employment | 96 (28.2) | 55 (28.5) | 151 (28.3) | |
Partner statusc** | < 0.001 | |||
Living together (married/unmarried) | 20 (5.9) | 172 (88.7) | 192 (36.0) | |
Not living together (married/unmarried) | 303 (89.1) | 21 (10.8) | 324 (60.7) | |
No current partner*** | 17 (5.0) | 1 (0.5) | 18 (3.4) | |
Method at ECHO exit/CUBE enrollment | 0.69 | |||
LNG implant (Jadelle) | 113 (33.1) | 70 (35.9) | 183 (34.1) | |
Copper IUD | 89 (26.0) | 45 (23.1) | 134 (24.9) | |
3-month injectable | 140 (40.9) | 80 (41.0) | 220 (41.0) | |
Contraceptive method using at COVID survey | < 0.001 | |||
None | 34 (9.9) | 61 (31.3) | 95 (17.7) | |
LNG implant (Jadelle) | 77 (22.5) | 47 (24.1) | 124 (23.1) | |
ENG implant (Implanon) | 5 (1.5) | 3 (1.5) | 8 (1.5) | |
Copper IUD | 72 (21.1) | 29 (14.9) | 101 (18.8) | |
2-month injectable | 3 (0.9) | 0 (0.0) | 3 (0.6) | |
3-month injectable | 107 (31.3) | 46 (23.6) | 153 (28.5) | |
Oral contraceptives | 4 (1.2) | 6 (3.1) | 10 (1.9) | |
Male/female condoms | 39 (11.4) | 2 (1.0) | 41 (7.6) | |
Standard Days Method/Cycle Beads | 1 (0.3) | 1 (0.5) | 2 (0.4) |